4.62BUSD
0.46
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US37890U1088
CUSIP
37890U108
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-0.30
Book Value
1.76
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-4.864
Wall Street Target Price
64.50
EPS Estimate Current Year
-4.17
EPS Estimate Next Year
-2.35
EPS Estimate Current Quarter
-1.18
EPS Estimate Next Quarter
-1.1
Most Recent Quarter
-
Revenue TTM
234,860,992
Gross Profit TTM
191,433,000
EBITDA
-293,191,008
Profit Margin
-137.30%
Return On Assets TTM
-25.18%
Return On Equity TTM
-148.56%
Revenue Per Share TTM
3.643
Qtly Revenue Growth YOY
50.50%
Diluted Eps TTM
-4.864
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
19.6774
Price Book MRQ
39.0457
Enterprise Value Revenue
20
Enterprise Value EBITDA
-16
162.19
7.06%6.55
7.03%3.38
5.63%75.15
2.36%79.34
0.48%33.40
-1.13%515.02
-0.49%444.38
-0.39%108.68
-0.16%28.09
-0.14%